Yehonatan Medical, an Israeli startup, is working tirelessly to help resolve the shortage of ventilators in that country’s COVID-19 intensive care units. A revolutionary type of multi-patient ventilator is under development along with partner Dr. Ori Efrati, director of the Pediatric Pulmonary Unit at Sheba Medical Center. This novel ventilation system can actually be used by 3 to 5 patients in parallel, leading to more coverage for the life-saving services.
This Yehonatan Medical ventilation product uses a relatively simple and economical technology that includes an embedded disinfection system. The BiPAP non-invasive ventilation machine includes a remote interface that supports patient monitoring from a safe distance.
Innovation Takes Collaboration
The company was founded by an engineer and scientist named Michael Cohen, who worked on the design of the investigational product with the help of cardiologist, such as Dr. David Adams at Mount Sinai Hospital in New York City, Dr. David Tirone of Toronto General Hospital and Dr. Gideon Cohen of Sunnybrook Health Sciences Center. With the potential to treat up to 5 patients in parallel, this device is a potential game changer.
Presently under advanced investigation at the MSR Medical Simulation Center at Sheba, the focus now is the testing of the product on artificial lungs. If the device becomes approved sales should take off.